Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-32 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-32 |
filingDate |
1990-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1992-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41beaec73e7e5da39e2434e000fad31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c5daef43e49d4d34c9369d5f350b036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d60598622cd9a19c024dbec6185faf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02463fe070e48fdb13d756888114e7e |
publicationDate |
1992-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5089522-A |
titleOfInvention |
Antitumor antibiotic BU-3285T |
abstract |
The present invention relates to the antitumor antibiotic compound BU-3285T and its preparation. The compound is obtained by culturing a new strain of Chainia rosea and demonstrates both antitumor and antifungal activity. It also relates to the desulfated derivative of BU-3285T which is obtained by treatment of BU-3285T with sulfatase enzyme. BU-3285T desulfate possesses antitumor activity. |
priorityDate |
1989-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |